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Protocol
AbstrACt
Introduction Prevention of overweight and obesity in 
childhood is a priority because of associated acute and 
chronic conditions in childhood and later in life, which 
place significant burden on health systems. Evidence 
suggests prevention should engage a range of actions 
and actors and target multiple levels. The Whole of 
Systems Trial Of Prevention Strategies for childhood 
obesity (WHO STOPS) will evaluate the outcomes of a 
novel systems-based intervention that aims to engage 
whole communities in a locally led multifaceted response. 
This paper describes the planned economic evaluation of 
WHO STOPS and examines the methodological challenges 
for economic evaluation of a complex systems-based 
intervention.
Methods and analysis Economic evaluation alongside 
a stepped-wedge cluster randomised controlled trial 
in regional and rural communities in Victoria, Australia. 
Cost-effectiveness and cost–utility analyses will provide 
estimates of the incremental cost (in $A) per body 
mass index unit saved and quality adjusted life year 
gained. A Markov cohort model will be employed to 
estimate healthcare cost savings and benefits over the 
life course of children. The dollar value of community 
resources harnessed for the community-led response 
will be estimated. Probabilistic uncertainty analyses will 
be undertaken to test sensitivity of results to plausible 
variations in all trial-based and modelled variables. WHO 
STOPS will also be assessed against other implementation 
considerations (such as sustainability and acceptability to 
communities and other stakeholders).
Ethics and dissemination The trial is registered by 
the Australian New Zealand Clinical Trials Registry 
(ACTRN12616000980437). Full ethics clearances 
have been received for all methods described below: 
Deakin University’s Human Research Ethics Committee 
2014-279, Deakin University’s Human Ethics Advisory 
Group-Health (HEAG-H) HEAG-H 194_2014, HEAG-H 17 
2015, HEAG-H 155_2014, HEAG-H 197_2016, HEAG-H 
118_2017, the Victorian Department of Education and 
Training 2015_002622 and the Catholic Archdiocese of 
Ballarat. Trial findings (including economic evaluation) will 
be published in peer-reviewed journals and presented at 
international conferences. Collected data and analyses 
will be made available in accordance with journal policies 
and study ethics approvals. Results will be presented to 
relevant government authorities with an interest in cost-
effectiveness of these types of interventions.
trial registration number ACTRN12616000980437; Pre-
results. 
IntroduCtIon 
Childhood obesity causes a range of acute and 
chronic conditions reducing mental and phys-
ical health and well-being.1–3 Obese children 
are at higher risk of becoming obese adults, a 
major risk factor for diabetes, cardiovascular 
disease and some cancers.1 4 5 WHO estimates 
that 23% of children living in developed 
strengths and limitations of this study
 ► The protocol for this novel and complex interven-
tion is guided by the Consolidated Health Economic
Evaluation Reporting Standards guidelines for eco-
nomic evaluation and draws lessons from the liter-
ature on the economic evaluation of complex public
health interventions.
 ► Pragmatic solutions are discussed for the core chal-
lenges this complex intervention poses for econom-
ic evaluation (eg, defining intervention boundaries;
measurement and attribution of costs to Whole
of Systems Trial Of Prevention Strategies (WHO
STOPS)).
 ► A range of data collection approaches will be em-
ployed to identify and measure the resources con-
tributed across multiple sectors in participating
communities.
 ► WHO STOPS will be assessed against other imple-
mentation considerations (strength of evidence,
equity, acceptability to stakeholders, sustainabil-
ity, feasibility of implementation and potential side
effects).
 ► This protocol provides the core elements for the
economic evaluation of this adaptive multifaceted
whole of systems approach. Further decisions may
be required that have not yet been considered.
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countries are overweight or obese.6 In Australia, the most 
recent National Health Survey (2014–2015) indicates 
that 27% of children aged 7–12 years are overweight or 
obese.7 It is estimated the direct costs of obesity to the 
health system were $8.6 billion in the 2011/2012 finan-
cial year.8 Preventing the onset of overweight and obesity 
during childhood could improve physical and psycholog-
ical well-being, and education outcomes for children, and 
reduce the health burden and healthcare costs during 
childhood and later life.9–12 
While many different types of interventions to prevent or 
treat childhood obesity have been trialled,13 14 these have 
generally shown limited feasibility and/or success. In the 
absence of successful interventions, invasive procedures 
such as bariatric surgery have increasingly been used to 
reduce body mass index (BMI) in teens with obesity as well 
as children as young as 9 years.15 However, these procedures 
are costly to the health system and are a high risk rather 
than population-level solution.9 Downstream interven-
tions targeting at-risk children and their parents through 
screening and provision of primary-care-based interven-
tions have generally been ineffective in reducing BMI.16 
Of the more upstream interventions, few achieved reduc-
tions in the BMI of children,13 and those that did, have not 
demonstrated long-term benefits.13 17 The most promising 
strategies for preventing childhood obesity appear to be 
multifaceted—engaging a range of actions and actors to 
target multiple risk factors across multiple levels (eg, indi-
viduals, schools and whole communities).13 18
Building on the existing evidence, the Whole of 
Systems Trial Of Prevention Strategies for childhood 
obesity (WHO STOPS) will evaluate the impact of a novel 
intervention that aims to engage whole communities in 
a locally led multifaceted response.19 This systems-based 
intervention is underpinned by systems thinking20 21 
and collective impact.19 22 WHO STOPS aims to reduce 
childhood BMI-z and obesity prevalence by supporting 
community leaders to change food and physical activity 
(PA) environments and related behaviours.19
Assessing cost-effectiveness of new interventions is crit-
ical to priority setting and funding decisions.23 24 There 
are few trials employing systems-based thinking for child-
hood obesity prevention and consequently little rigorous 
evaluation of cost-effectiveness of these approaches.25 
This is due to the relatively recent emergence of this 
approach to childhood obesity prevention and also the 
methodological challenges for economic evaluation, 
where well-established economic evaluation frameworks 
provide only limited guidance on assessing complex and 
adaptive interventions.26 27 That said, modelling and trial-
based evidence suggests multifaceted preventive strate-
gies—particularly targeting schools—have real potential 
to be cost-effective,28–30 making the case for a rigorous 
economic evaluation of WHO STOPS. This paper pres-
ents a protocol (incorporating a discussion of key chal-
lenges) for the economic evaluation of the WHO STOPS 
childhood obesity intervention to address the research 
question:
From the funder/organiser and societal perspectives, 
what is the cost-effectiveness of the WHO STOPS 
childhood obesity intervention compared with cur-
rent practice in regional and rural communities in 
Victoria, Australia?
About thE trIAl
study design
WHO STOPS is a stepped-wedge, cluster randomised 
controlled trial (C-RCT). The trial design is described 
in detail in Allender et al.19 In brief, 10 dispersed clus-
ters or ‘natural communities’ (based on existing local 
government, health service and education boundaries) 
in the South Western Region of Victoria (Australia) were 
randomly assigned to receive the intervention at step 1 
(2017)—referred to as intervention communities, or step 
2 (2019) referred to as control communities (see table 1). 
Note that the timing of implementation has been updated 
from Allender et al.19 The region has 360 000 inhabitants 
and population clusters range in size from around 3200 
to 20 800 people.
the intervention
The intervention has three main components.
Community engagement and facilitation (component 1)
First, community leaders will engage in at least two group 
model building (GMB) sessions. The research team 
will facilitate the construction of a causal loop diagram 
(CLD) that visually describes from the community 
leaders’ points of view, the shared understanding of the 
drivers of childhood obesity in their community and the 
interactions between such drivers.20 21 31 Figure 1 provides 
an example of a community leaders’ CLD.32 All commu-
nity members are then invited to participate in a whole 
of community session (or sessions), where participants 
will (1) review the CLD, (2) identify points across the 
CLD where community-led actions to reduce obesity-re-
lated risk factors can be designed and implemented and 
(3) form community action groups to take ownership of
these proposed actions.
Built on a behavioural and anthropometry school-
based monitoring programme, childhood obesity and 
associated risk factor data collected in primary schools of 
the same community (see Crooks et al33) will be presented 
during the GMB and whole of community sessions.
Table 1 Whole of Systems Trial Of Prevention Strategies 
stepped-wedge cluster randomised controlled trial design
Community
Preintervention 
baseline
(2015–2016)
Step 1
(2017–2018)
Step 2
(2019–2020)
Group 1 (five 
communities)
Control Control Intervention
Group 2 (five 
communities)
Control Intervention Intervention
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Backbone organisation (component 2)
The WHO STOPS process uses a collective impact 
approach,19 22 which seeks to identify and support a local 
‘backbone’ organisation that will take significant respon-
sibility for fostering, supporting and monitoring the 
community-led actions (described in component 3). It 
is anticipated that this role will include facilitating WHO 
STOPS action planning and review meetings, tracking 
and providing feedback of community-led actions to 
the community. During a pilot testing phase in a prox-
imal, comparable town, the backbone organisation was 
a locally based public health organisation that allocated 
personnel time to these tasks.
Components 1 and 2 capture the reproducible element 
of the intervention and will be directly facilitated by 
the implementation specialists from the WHO STOPS 
research team. The timing of the establishment of the 
backbone organisation, however, may occur prior to, 
during or after component 1. The end of the whole of 
community session(s), where community-led actions are 
agreed on, will mark the full implementation of the inter-
vention dose.
Community-led actions (component 3)
Component 3 consists of the planning and implementa-
tion by community members, of the suite of actions iden-
tified in their whole of community sessions, as well as any 
actions subsequently taken in the community that were 
motivated by component 1. The aim will be to undertake 
numerous actions across multiple points in the commu-
nity, thereby addressing a range of obesity-related risk 
factors. Actions might be led by community organisations 
(including local government, health services, schools and 
sporting clubs), businesses, community groups or individ-
uals. Any resources required to implement the proposed 
actions will be sourced by communities, primarily from 
within existing community resources. This strategy will 
result in component 3 being unique in each of the five 
intervention communities.
Control communities
Current practice will be observed in control (step 2) 
communities. This will include any local strategies targeting 
obesity-related risk factors implemented at the community 
level. Current practice itself is dynamic as communities 
Figure 1 Sample of a causal loop diagram.32
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introduce new and phase-out old local strategies. Imple-
mentation of the intervention in control communities will 
be completed 2 years after implementation in intervention 
(step 1) communities (2019) (see table 1).
ChAllEngEs for ConduCtIng EConoMIC EvAluAtIon of A 
wholE of systEM IntErvEntIon
The characteristics of this novel systems-based childhood 
obesity prevention strategy introduce a number of prac-
tical challenges for the application of standard economic 
evaluation methods.
defining the intervention
From the funder/organiser perspective, the interven-
tion could be viewed as limited to component 1, with the 
establishment of a backbone organisation (component 2) 
and the range of community actions generated (compo-
nent 3)—important intermediate outcomes. However, 
from a broader societal perspective, those (component 
3) community actions are a prerequisite for obesity-re-
lated behaviour change and as such can be considered an
active component of the intervention. From this perspec-
tive, understanding the resources harnessed from within
the community to affect any potential change in child-
hood overweight and obesity is important. Adding further
complexity, each community will develop its own non-pre-
scribed set of actions—as a result of differing priorities
(determined via component 1), and at least partly as a
result of the capacity provided by their backbone organi-
sation and the approach it takes. As a result, each commu-
nity’s component 3 will be unique, non-standardised and
tailored to its own specific needs and resource capacity.
Assessing the costs
While costing components 1 and 2 will be relatively 
straightforward, the task of costing component 3 will be 
large and complex. Implemented actions (component 3) 
will occur across numerous sectors/settings (eg, health, 
education, local government, transport, local commerce, 
sport and recreation), making identification of costs 
difficult. Implementing parties may be well defined (eg, 
local department of health, local municipal government, 
school, sports club) or smaller and informal (eg, house-
holds or a group of parents). Beyond identification, ‘best 
practice’ microcosting of the potentially hundreds of 
discrete actions that may result across multiple communi-
ties is not feasible given this and most research projects’ 
resource constraints.
Attributing costs of a community action to the interven-
tion in itself provides challenges particularly when:
a. An action has a set of aims and/or target group
broader than children.
b. An action was motivated by observing other activities
in theirs or other communities, rather than resulting
from participation at the original community GMB
sessions (ie, how many degrees of separation should
be allowed for spin-off actions to be included?).
c. The intervention was only a tipping point, where
years of community attention afforded a given ac-
tion brought the community to a point of readiness
to implement.
d. An action is somewhat distal to the primary aim of
the intervention but was identified as an obesity-re-
lated risk factor by that community (eg, targeting
parental drug and alcohol use to improve parenting
skills).
While not unique to this intervention, this research 
is part of a much larger research effort and there is a 
genuine risk of overburdening community members with 
data collection at the risk of undermining community 
support.34 The costing method applied requires achieve-
ment of a balance between data comprehensiveness, 
feasibility and community sensitivity.
Assessing the benefits
The benefits of the whole of systems intervention may extend 
beyond the primary outcome and target population. For 
example, any resulting improvement in a child’s eating and 
PA behaviours may extend to other household members,35 
or the strengthening of a community’s networks and lead-
ership may improve its capacity to address other health and 
non-health related issues.36 Further, the intervention may 
result in multiple community actions, which are iterative 
in their development and interact in a non-linear fashion 
creating intended and unintended consequences, either of 
a positive or negative nature.37 38 Such a systems-based inter-
vention seeks to create ‘system shifts’ and establish new soci-
etal norms around obesity-related behaviours; predicting 
the nature and extent of change beyond the trial period 
is difficult. These innovative intervention strategies require 
novel assessment techniques or adaptation of existing 
methods. Scenario analyses using system dynamics models37 
may provide a framework to predict the likelihood of such 
system shifts (the potential use of which will be explored in 
this trial).
lessons from the literature
The Consolidated Health Economic Evaluation Reporting 
Standards guidelines for reporting economic evalua-
tions26 remain generally appropriate for this systems-based 
intervention, and some relevant lessons can be drawn 
from economic evaluations of complex public health 
interventions that share some of these challenges.35 38–42 
However, the level of detail embedded in these resources 
is insufficient to provide practical guidance on all of the 
methodological decisions required.43 Frew35 argues (in 
the context of childhood obesity interventions) that such 
challenges require creativity, with decision rules made 
and justified on a case-by-case basis, while keeping the 
needs of decision-makers foremost in mind.
MEthods And AnAlysIs
Economic evaluation overview
A cost-effectiveness evaluation will be conducted with 
incremental cost-effectiveness ratios calculated for the 
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cost ($A) per BMI unit saved and quality adjusted life 
year (QALY) gained. Results will be analysed at the 
commencement of step 2 implementation (2019), when 
a comparison of the intervention versus current practice 
can be made. Results will also be analysed after 4 years 
(2 years post step 2 implementation (2021)) to identify 
the evolution and sustainability of community responses 
(including resource use) and any treatment effect. 
Analyses of intention-to-treat and as-per-protocol (ie, 
reaching component 3) treatment effects will be under-
taken. Costs and benefits will be modelled over the rest 
of life, until the study cohort of children has either died 
or reached 100 years of age. The dollar value of commu-
nity resources harnessed for $1 investment into compo-
nent 1 will also be estimated. All costs will be inflated to 
current Australian dollars for the year of study comple-
tion using the all-items Consumer Price Index from the 
Australian Bureau of Statistics. All costs and benefits will 
be converted to present values using an annual discount 
rate of 5% in the base case, and annual rates of 3.5% and 
0% in sensitivity analysis.44
Two perspectives will be taken. First, a funder/organ-
iser perspective will be adopted, where the relevant 
intervention costs pertain to components 1 and 2. This 
perspective is broadly equivalent to what Frew35 describes 
as a ‘local authorities’ perspective, where a community’s 
leaders in local government, health services and primary 
schools (each having remit over health and well-being of 
children in their communities), will (collectively) be most 
likely responsible for sourcing funds to facilitate the first 
component of a WHO STOPS style strategy beyond the 
trial setting, as well as providing resources for the back-
bone role (component 2). As such, this perspective will 
have most utility for local decision-makers. Depending 
on the funding source of the identified backbone organ-
isations, it is possible that this funder/organiser perspec-
tive will overlap significantly with a state government 
perspective. Second, a societal perspective will be taken, 
which will include the costs of resources contributed by 
the broader community through component 3, as well 
as future health system cost offsets. While it is expected 
that community actions will largely be resourced by real-
locations of existing resources and funds, the associated 
opportunity costs require identification. This perspective 
will be of value for funding decision-making at higher 
levels (eg, state, national) where broader comparisons of 
relative cost-effectiveness within and across health silos 
are made, as well as for communities considering such a 
strategy, so they are fully aware that any treatment effect 
observed in this trial may have been mediated by the scale 
of community resources (eg, volunteer hours) contrib-
uted in those communities.
Given the burden associated with costing, the costing of 
components 2 and 3 will be restricted to two intervention 
communities and two control communities. These will be 
selected by the research team in consultation with external 
partners using the following considerations: (1) there 
is comparability in the population size of intervention 
and control communities, (2) the selected communities 
have some generalisability from the perspective of deci-
sion-makers, and (3) the backbone organisation agrees 
to participate in data provision and collection for the 
economic evaluation. To capture broader, less quantifi-
able issues that are of concern to policy-makers, WHO 
STOPS will also be assessed against other implementation 
considerations (strength of evidence, equity, acceptability 
to stakeholders, sustainability, feasibility of implemen-
tation and potential side effects) as per the approach 
developed and employed by Carter et al.45 These will be 
assessed by the research team in consultation with back-
bone organisations and other community partners.
Identification, measurement and valuation of outcomes
Health and health-related behavioural outcomes
Primary (BMI change) and secondary (PA and dietary 
behaviours) outcome data will be collected from chil-
dren aged between about 8 and 12 years at partici-
pating primary schools using opt-out (passive) consent 
as described in Crooks et al33 and the intervention effect 
assessed as described in Allender et al.19 PA and dietary 
behaviour questions will be self-completed, with students 
given structured prompts on how to answer the questions 
or to clarify terminology (as is the case for Health-Re-
lated Quality of Life (HRQoL) Questionnaire—discussed 
below).
Quality of life
HRQoL data will be collected (see Crooks et al33) using the 
PedsQLTM 4.0 Child Report (8–12 years). The PedsQL is 
a non-preference-based 23 item instrument that assesses 
functioning across physical, emotional, social and school 
domains, where responses are transformed to a score 
on a 0–100 scale; higher scores reflect better HRQoL.46 
Given PedsQL is a non-preference-based HRQoL instru-
ment, an algorithm will be developed to enable conver-
sion of PedsQL overall scores of study participants to the 
preference-based Children’s Health Utility 9 Dimension 
Index.47 48 Specifically, a dataset of around 1800 Australian 
children aged between 10 and 12 years will be employed. 
Following best practice methods, the optimal mapping 
algorithm will be chosen based on a series of econometric 
techniques using a number of goodness-of-fit measures.47 
This will enable estimation of any resulting QALY gains.47
System changes
Proxy indicators of system change will be measured 
at baseline and followed up annually. The number of 
community actions will be tracked (and dollar value of 
resources utilised estimated) as proxies of communi-
ty-level engagement. Social network analysis methods will 
be used to measure structural changes in community lead-
ership networks.49 Assessments of changes in the obesity 
policy, infrastructure and leadership environment will be 
measured through a readiness to change analysis.50 These 
indicators will inform analysis of the other implementa-
tion considerations.
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Future health and HRQoL benefits
An existing multistate life table Markov model will be 
used. Described in detail in Brown et al,51 the model esti-
mates (for the 2010 Australian population) the extent 
to which changes in BMI and PA (independent of BMI) 
impact on the incidence and associated healthcare costs 
of osteoarthritis of the knee and hip, breast cancer, colon 
cancer, endometrial cancer, kidney cancer, ischaemic 
heart disease, hypertensive heart disease, stroke and type 
2 diabetes; all causally related to obesity. The model was 
built in Excel (Microsoft Office 2003) and uses the add-in 
tool Ersatz (EpiGear, V.1.0) for uncertainty analysis.
IdEntIfICAtIon And MEAsurEMEnt of Costs
Table 2 summarises the cost inclusions and data collection 
strategy for components 1, 2 and 3. The planned approach 
for identification and measurement of costs will use a 
community’s backbone organisation to track community 
actions and collect data on related resource use for plan-
ning and implementation of given actions. A community 
action register, which is designed for tracking community 
actions and associated resource use, will be provided to 
each community’s backbone organisation. This will facil-
itate data collection for economic evaluation purposes as 
well as aid each community’s own monitoring and evalu-
ation. This approach has been developed in collaboration 
with team members of such a backbone organisation and 
takes into consideration their capacity to collect data for 
research purposes, which may be beyond their own data 
needs for evaluation and community feedback.
Should an action result in an organisation moving funds 
between obesity-related programmes (ie, no net change in 
obesity-related programme funding), the costs associated 
with the newly funded activity will not be included in the 
cost-effectiveness analysis, though the new activity will be 
identified and documented. Given the intractability of such 
data — any changes in household expenditure on food and 
PA, and changes in revenue flowing to local retailers as a 
result of component 3 actions will be excluded. The costs 
of designing and developing the process for engaging and 
facilitating community actions (component 1), and Systems 
Thinking in Community Knowledge Exchange software 
will be excluded as they largely pre-exist this trial and will 
have wider use beyond this childhood obesity prevention 
intervention.
To assess the extent to which an identified action is 
attributable to WHO STOPS, at least two backbone team 
members (or relevant key informants) will respond to the 
following questions for each identified action: (1) Was the 
action commenced after Component 3 was implemented? 
(2) Is there a known link between WHO STOPS and the
action? (3) Were any participants in planning or imple-
menting the given action also involved in any WHO STOPs
GMB sessions? (4) Was the implemented action intended to 
directly or indirectly address childhood obesity? (5) What
proportion of the target population were children? (6)
Were new resources allocated to obesity-related actions? (7)
To what extent do you think the WHO STOPS intervention 
motivated implementation of the given action—(select one 
response: not at all, a little, somewhat, a lot, completely).
Given the intrinsic variability of component 3 of the inter-
vention, it is possible that comprehensive costing of only 
two of the five communities might not provide an accu-
rate representation of the potentially large between-com-
munity heterogeneity of actions and costs involved in 
this component. As a way to investigate this variability, all 
communities will be encouraged to monitor community 
actions and resource contributions using the community 
action register. Prior to finishing the economic evaluation, 
results from the costing of the two selected intervention 
communities will be discussed with backbone organisa-
tions from all intervention communities. Those backbone 
organisations from communities not comprehensively 
costed will be asked to consider those results alongside the 
actions registered in their own registers, and reflect on the 
extent to which findings appear consistent with their own 
communities. If perceived heterogeneity is raised, this will 
be acknowledged as a limitation in the published economic 
evaluation results.
The collection of resource use data relating to current 
practice in the control communities will differ in some 
respects. Backbone organisations will not be actively estab-
lished by the research team until close to step 2 implemen-
tation. This will minimise researcher-led contamination of 
the control communities, but will result in a reliance on 
retrospective identification of community actions in those 
communities (as set out in table 1) and raises the risk of 
failing to identify ‘current practice’ actions that occurred. 
This potential for recall bias reinforces the importance of 
taking steps to assess attribution of actions to WHO STOPS 
in the intervention communities.
vAluAtIon of rEsourCE usE
The time contributions of individuals (professional and 
volunteer time) will be costed using opportunity cost prin-
ciples. Resource use of non-health sector goods and services 
will be valued at market prices and be informed by best 
available evidence from Australian-based studies. Where 
relevant, health resources will be costed as per the Manual 
of Resource Items for use in submissions to the Common-
wealth of Australia's Pharmaceutical Benefits Advisory 
Committee.44
Where the data collection strategy results in insuf-
ficient detail for an identified community action, 
evidence of costs may be drawn from comparable 
community-based obesity prevention activities. The 
anticipated large number of community-led actions 
likely to be identified and logged in a backbone’s action 
register will deem it infeasible to collect detailed data on 
resource use for each registered action. As such, each 
action will be classified into small, medium and large 
(in terms of resource intensity) by backbone organisa-
tion personnel. A sample from each classification will 
then be costed in detail, with results extrapolated.
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unCErtAInty And sCEnArIo AnAlysEs
It is important to note some of the challenges being 
faced that may have implications for the estimated 
treatment effect. The intervention aims to make system-
level changes, some of which will take longer than the 
trial period to occur. Further, due to the variability we 
have observed in the time it takes communities to reach 
the component 3 stage (community actions), it is likely 
there will be variable effects measured across communi-
ties after 2 years. The 4-year analyses to be undertaken 
will be comparing a maximum of 4 years of exposure 
(step 1 communities) versus a maximum 2 years of 
exposure (step 2 communities) rather than comparing 
against a current practice control. However, BMI 
change data are being collected from a small number of 
schools in 13 communities external to the WHO STOPS 
study.52 The methods of data collection and general 
characteristics of the surveyed schools differ from the 
current study. So, while these external communities do 
not constitute the ideal control group, several of the 
external communities are comparable (in terms of 
population and geographic proximity to major urban 
centres). These external communities will provide an 
indication of BMI trends in non-WHO STOPS settings. 
This will facilitate the estimation of plausible variations 
in treatment effects at 2 and 4 years for use in sensitivity 
analyses.
It is possible that other family members of targeted 
children and the broader community may also benefit 
from the WHO STOPS intervention in terms of BMI 
change.35 Furthermore, the intervention may result 
in (1) productivity gains (given potentially reduced 
child absenteeism from school for obesity-related 
reasons leading to lower parent absenteeism from 
work), and (2) improved future income levels arising 
from improved schooling outcomes.53 54 Best available 
evidence on such broader potential costs and benefits 
will be sought and included in scenario analyses.
Given uncertainty around the maintenance of commu-
nity responses and treatment effects beyond the trial period, 
modelling of future benefits and health cost savings will 
test a range of plausible assumptions of decayed and main-
tained treatment effect. These may range from full decay 
over 5 or 10 years through to 100% maintenance of effect. 
In the event that within trial analyses of the proxy indica-
tors of system change suggest an accentuation of treatment 
effect is plausible, modest accentuation of treatment effect 
will also be modelled.
Extensive analyses will be undertaken to test the 
sensitivity of results to plausible variations in all trial-
based and modelled variables, including assumptions 
around the maintenance of any observed changes in 
BMI (as discussed above), PA and fruit and vegetable 
consumption as well the costs of alternative approaches 
to GMB facilitation (where local community members 
are trained to facilitate). Further, in the event that BMI 
changes are observed in children, the potential impact 
on the intervention’s cost-effectiveness of broader 
‘family effects’ will be investigated in scenario analyses. 
The potential for system dynamics models to estimate 
the impact of ‘system-wide’ changes on future obesi-
ty-related behaviours and prevalence will be explored 
and considered for use in scenario analyses.
ConClusIon
Obesity is associated with poorer health and quality of life—
its prevalence is high and rising in many countries.55 Child-
hood obesity can have detrimental health and well-being 
implications during childhood and is a major predictor of 
obesity in adulthood and its serious and expensive associ-
ated conditions.5 Community-based strategies have been 
effective in achieving some reductions in population BMI, 
but these have not been sustained. The WHO STOPS inter-
vention builds on this evidence base. It seeks to harness 
existing community resources and expand the extent of 
local engagement in obesity-risk reduction, across whole 
communities.
Evaluating the cost-effectiveness of this novel systems-
based intervention will help policy-makers by assessing 
the resource use implications of achieving any observed 
intervention effect. This protocol considers the main 
challenges posed by the economic evaluation of such 
a complex intervention designed to produce systems 
change. This protocol registers our intent to conduct 
this evaluation alongside the WHO STOPS Childhood 
Obesity Trial, and describes for transparency, the prede-
termined approaches for addressing the methodolog-
ical challenges described and the analyses planned a 
priori. This does not preclude additional hurdles arising 
during the course of the project forcing additions to or 
deviations from this plan, but these will be openly docu-
mented during the reporting of results.
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